NEW YORK (GenomeWeb) – OpGen today raised the amount it plans to publicly offer in stocks and warrants to up to $15.6 million,

The firm previously said it planned to offer up to $10 million in stocks and warrants.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.